GENMAB AS SP.ADR/1/10DK 1 (GE91) — Defensive Interval Ratio
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Defensive Interval Ratio of 284 days as of December 2025. Defensive assets of €1.11 Billion (cash €-, short-term investments €0.00, receivables €1.11 Billion) cover 284 days of daily cash needs of €3.91 Million/day. See GENMAB AS SP.ADR/1/10DK 1 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
GENMAB AS SP.ADR/1/10DK 1 Defensive Interval Ratio (2021–2025)
This chart shows how GENMAB AS SP.ADR/1/10DK 1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 284 days, meaning defensive assets of €1.11 Billion can fund 284 days of operations without new revenue. See GENMAB AS SP.ADR/1/10DK 1 balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see GENMAB AS SP.ADR/1/10DK 1 (GE91) total market value.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 284 days | €1.11 Billion | €3.91 Million/day | €- | €0.00 | ▼ -944 days |
| 2024 | 1228 days | €2.49 Billion | €2.03 Million/day | €- | €1.57 Billion | ▼ -1447 days |
| 2023 | 2675 days | €2.70 Billion | €1.01 Million/day | €- | €1.97 Billion | ▼ -958 days |
| 2022 | 3633 days | €2.61 Billion | €718.85K/day | €- | €1.79 Billion | ▲ +432 days |
| 2021 | 3200 days | €2.09 Billion | €653.99K/day | €- | €1.58 Billion | — |